Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Hospital Pablo Tobón Uribe | OTHER |
| Clínica CES | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to evaluate the latency period (timing between the injection of the local anesthetic and the onset of complete sensory nerve block) of two approaches for ultrasound-guided popliteal sciatic nerve block: One of the approaches is the injection of the anesthetic just at the site of the bifurcation of the sciatic nerve and the other one is injecting the local anesthetic at least 2 cm beyond the bifurcation of the aforementioned nerve. Our main hypothesis is that the first approach will decrease the latency period, and probably, will increase the success rate of the nerve block as well as patient satisfaction.
Compare the effectiveness of nerve blockade at the bifurcation site of the sciatic nerve versus distal (tibial and peroneal) using only levobupivacaine 0.5%. The primary outcome is the latency period of the nerve blockade; the secondary outcomes are rate of success of the procedure as well as patient satisfaction.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Sciatic nerve blockade at bifurcation | Experimental | Ultrasound-guided block at the bifurcation of the sciatic nerve |
|
| Sciatic block 2 cm beyond bifurcation | Experimental | Ultrasound-guided block of the sciatic nerve 2 cm beyond of the bifurcation |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Sciatic nerve anesthesia blockade at bifurcation. | Procedure | A proximal and distal initial scan and define the site to block the bifurcation. A puncture with an insulated needle guided by ultrasound and injection of levobupivacaine circumferential in 0.5% and a total volume of 20 mL. |
| Measure | Description | Time Frame |
|---|---|---|
| Latency period of sciatic nerve block. | Once the nerve blockade is done, a sensory evaluation will be performed in the surgical area every five minutes to determine the onset of the sensory nerve blockade in minutes. | 5 minutes, 10 minutes, 15 minutes, 20 minutes, 25 minutes and 30 minutes after nerve block. |
| Measure | Description | Time Frame |
|---|---|---|
| Success of sciatic nerve block | The time to achieve a complete sensory nerve block, reached maximum at 30 minutes, in full distribution of tibial nerve and common fibular nerve for anesthesia. | Every 5 minutes until 30 minutes until the end of the procedure for the nerve block; an additional measure will be performed at the end of of the surgery. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Marta I Berrio, MD | Contact | +57 301 4839308 | martaberrio@gmail.com | |
| Juan-Felipe Vargas, MD | Contact | +57 311 6306919 | vargasj@une.net.co |
| Name | Affiliation | Role |
|---|---|---|
| Marta I Berrio, MD | CES University, Medellín, Antioquia, Colombia | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospital Pablo Tobón Uribe | Medellín | Antioquia | 050034 | Colombia |
Not provided
Not provided
Not provided
Not provided
Not provided
|
|
| Sciatic nerve blockade 2 cm beyond the bifurcation | Procedure | A proximal and distal initial scan and define the sites to block: tibial and peroneal nerves separate distal 2 cm from the bifurcation site. A puncture with an insulated needle guided by ultrasound and injection of levobupivacaine circumferential in 0.5% 10 mL tibial nerve and 10 mL to the peroneal nerve. |
|
|
| Levobupivacaine 0.5%: 20 ml | Drug | Levobupivacaine is a local anesthetic that is commonly use for anesthesia nerve blockade. |
|
|
| Portable Ultrasound Machine: Sonosite, M-Turbo, Bothell, WA | Device | An ultrasound machine is a device that is widely used for the correct placement of the local anesthetic for anesthesia nerve blockade. |
|
|
| Insulated Needle, (Stimuplex; Braun, Melsungen, Germany) | Device | This is a specific kind of needle that is widely used for anesthesia nerve blockade. |
|
|
| supplemental oxygen | Drug | supplemental oxygen during the block and/or during surgery |
|
|
| Midazolam | Drug | Intravenous midazolam for sedation during the block and/or during surgery |
|
| Intravenous analgesics | Drug | Intraoperative administration intravenous of dipyrone 30-50 mg/Kg and or intravenous ketoprofen 100 mg or diclofenac 75 mg or ketorolac 30 mg |
|
| Saphenous nerve block | Procedure | Depending on sensitive territory committed by the type of surgery suprapatellar saphenous nerve block guided by ultrasound with 100 mm Stimuplex needle and injection of levobupivacaine 0.5% (total volume: 5 ml). |
|
| Patient satisfaction | Using a categorical score we will measure satisfaction of nerve-block-procedure satisfaction and analgesia quality one day after surgery: patients will choose one of three options: no satisfied, satisfied or very satisfied. | Postoperative 24 hours |
| Sensory block | Evaluation in 5, 10, 15, 20, 25 and 30 minutes after the procedure in the distribution of the common peroneal and tibial nerves 0: Complete sensory block
| 5, 10, 15, 20, 25 and 30 minutes after the block is finished |
| Motor block | Evaluation in 5, 10, 15, 20, 25 and 30 minutes after the procedure in the distribution of the common peroneal and tibial nerves 0: Complete motor blockade
| 5, 10, 15, 20, 25 and 30 minutes of completion after the block is finished |
| First analgesic | Time of first analgesic requirement in postoperative | 5 minutes, 30 minutes, 24 hours postoperative |
| Visual analog scale at rest | Pain rating ranging from zero to ten VAS 0: no pain VAS 1-3: Mild pain VAS 4-6: Moderate Pain VAS 7-10: Severe pain | 5 minutes, 30 minutes, 24 hours postoperative |
| Dynamic visual analog scale | Pain rating ranging from zero to ten with the movement | 5 minutes, 30 minutes, 24 hours postoperative |
| Intraneural injection | Increased diameter nerve or visualized by ultrasound visualization of the needle into the nerve at the time of injection | At the time of injection and execution of the block |
| Vascular puncture | Puncture of one or more blood vessels to visualize the needle within the vessel or to aspirate blood during block | During the execution of the block |
| Paresthesia during the procedure | Paresthesia during the procedure | At the time of the execution of the block |
| Systemic toxicity of local anesthetics | Systemic toxicity of local anesthetics | During the execution of the block and 30 minutes after it |
| Hematoma | Hematoma | During and inmmediately after the execution of the block |
| Muscle weakness | Subjective reduction in muscle strength at 24 hours postoperative | 24 hours postoperative |
| Altered sensitivity | Subjective decreased sensitivity at 24 hours postoperative | 24 hours postoperative |
| Cramps postoperative | Feeling cramps within 24 hours of the block | 24 hours postoperative of the block |
| Punctures | Number of skin punctures during the block | During the block |
| Time for the execution of nerve block | Time from placement of the transducer for the initial scan to final withdrawal of the needle | In minutes: Time from placement of the transducer for the initial scan to final withdrawal of the needle |
| Clínica CES | Medellín | Antioquia | Colombia |
| ID | Term |
|---|---|
| D006215 | Hallux Valgus |
| D000844 | Ankylosis |
| ID | Term |
|---|---|
| D005530 | Foot Deformities |
| D009140 | Musculoskeletal Diseases |
| D007592 | Joint Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000077554 | Levobupivacaine |
| D000779 | Anesthetics, Local |
| D014463 | Ultrasonography |
| D010100 | Oxygen |
| D008874 | Midazolam |
| ID | Term |
|---|---|
| D002045 | Bupivacaine |
| D000813 | Anilides |
| D000577 | Amides |
| D009930 | Organic Chemicals |
| D000814 | Aniline Compounds |
| D000588 | Amines |
| D000777 | Anesthetics |
| D002492 | Central Nervous System Depressants |
| D045505 | Physiological Effects of Drugs |
| D020228 | Pharmacologic Actions |
| D020164 | Chemical Actions and Uses |
| D018689 | Sensory System Agents |
| D018373 | Peripheral Nervous System Agents |
| D002491 | Central Nervous System Agents |
| D045506 | Therapeutic Uses |
| D003952 | Diagnostic Imaging |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
| D018011 | Chalcogens |
| D004602 | Elements |
| D007287 | Inorganic Chemicals |
| D005740 | Gases |
| D001569 | Benzodiazepines |
| D001552 | Benzazepines |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D006571 | Heterocyclic Compounds |
Not provided
Not provided